The NExT trial: Protocol for a two-phase randomized controlled trial testing transcranial magnetic stimulation to augment exposure therapy for youth with OCD
Abstract Background Exposure with Response Prevention (ERP) is a first-line treatment for OCD, but even when combined with first-line medications it is insufficiently effective for approximately half of patients. Compulsivity in OCD is thought to arise from an imbalance of two distinct neural circui...
Saved in:
| Main Authors: | Christine Conelea, Claire Breitenfeldt, Alixandra Wilens, Linda Carpenter, Benjamin Greenberg, Jennifer Herren, Suma Jacob, Charles Lewis, Nicole McLaughlin, Bryon A. Mueller, Steve Nelson, Erin O’Connor, Giulia Righi, Alik S. Widge, Mark Fiecas, Kristen Benito |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-12-01
|
| Series: | Trials |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13063-024-08629-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Memantine augmentation of escitalopram in treatment of executive function among patients with obsessive-compulsive disorder (OCD): a double-blind placebo-controlled randomized clinical trial
by: Hasan Mirzazadeh, et al.
Published: (2025-06-01) -
Acceptability, feasibility, and effectiveness of internet-based cognitive behavior therapy for obsessive–compulsive disorder (OCD-NET): a naturalistic pilot trial during the COVID-19 pandemic in a psychiatric outpatient department in Germany
by: Elisabeth Kohls, et al.
Published: (2025-01-01) -
Are the Unified Protocols for Transdiagnostic Treatment of Emotional Disorders in Children and Adolescents as Effective for OCD as for Anxiety and Depression?
by: Lauren Milgram, et al.
Published: (2025-04-01) -
Neuropsychological and psychopathological correlates of insight in persons with OCD
by: Saima Ahmed, et al.
Published: (2025-05-01) -
Clarifying the prevalence of OCD: A response to reader comments
by: Ilenia Pampaloni, et al.
Published: (2024-11-01)